Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | Belfast Health & Social Care Trust |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement. |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 6 June 2025 |
| Application Deadline: |
All 3 notices for this procurement, oldest first.
(ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
(ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
(ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
Procurement of (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
Published contracts in the last 12 months
189
total contracts
£110.4m
total value
£13,803,922
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| — |
| Procurement ID (OCID): | ocds-h6vhtk-0519fe |
| Notice Reference: | 030610-2025 |